Discovering Therapies for Neuromuscular Disorders
Deep Genomics to collaborate with Wave Life Sciences to discover novel therapies for genetic neuromuscular disorders
CAMBRIDGE, Mass. U.S.A. and TORONTO, Ontario, Canada, April 10, 2018 - Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined diseases, and Deep Genomics Inc., the leading AI therapeutics company that is building a ...